外周肺动脉狭窄并非单心室通路的禁忌证
该回顾性研究纳入22例单心室生理合并外周肺动脉狭窄(PPAS)患者,采用积极外科重建策略。中位随访52个月无死亡,20例(90.9%)成功进入单心室通路,其中12例完成Fontan、8例双向Glenn等待Fontan,仅2例因肺动脉压升高未适合进展。结论认为PPAS不是单心室姑息的禁忌证。
要点
- PPAS患者经积极外科重建后90.9%可进入单心室通路
- 中位随访52个月无死亡,完成腔肺连接者均存活无症状
- 仅2例因肺动脉压升高未适合进展至单心室通路
核心结论
- PPAS不是单心室姑息的禁忌证,经仔细规划和积极早期外科重建,多数患者可成功进展至腔肺连接。
研究设计与样本
- 回顾性综述,纳入2008年4月至2020年3月共22例单心室生理且接受PPAS外科重建的患者。
- 手术策略为单期15例(68.2%)、二期7例(31.8%),取决于PPAS远端有无肺动脉发育不良。
主要发现
- PPAS类型为3型(叶级)19例(86.4%)、4型(段级)3例(13.6%)。
- 每例患者平均接受8±5.6次肺动脉血管成形术。
- 中位随访52个月(范围8-143个月)无死亡。
- 20例(90.9%)成功进入单心室通路,其中12例(54.5%)完成Fontan、8例(36.4%)完成双向Glenn等待Fontan。
- 2例(9.1%)因肺动脉压升高未适合进展至单心室通路;所有完成腔肺连接者存活无症状、无肺动脉压升高征象,无患者需再次干预肺动脉。
临床怎么用
- 对单心室生理合并PPAS患者,不应仅因PPAS放弃单心室通路,可考虑积极早期外科重建。
- 根据PPAS远端有无肺动脉发育不良选择单期或二期手术策略。
局限性
- 回顾性设计,样本量22例,来自单中心经验,随访时间范围较宽(8-143个月)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The presence of peripheral pulmonary artery stenosis (PPAS) involving lobar and/or segmental pulmonary artery (PA) branches might preclude proceeding to a single-ventricle pathway. We adopted a strict strategy for PA rehabilitation and surgical reconstruction in patients who are unable to progress to a single-ventricle pathway. METHODS: We conducted a retrospective review of 22 patients with single-ventricle physiology who underwent surgical reconstruction for PPAS from April 2008 to March 2020. Our surgical approach was single stage in 15 patients (68.2%) and 2 stage in 7 patients (31.8%) depending on the presence or absence of PA hypoplasia distal to the PPAS. RESULTS: The PPAS was type 3 (lobar) in 19 patients (86.4%) and type 4 (segmental) in 3 patients (13.6%). The mean number of PA angioplasties performed was 8 ± 5.6 per patient. There was no mortality in this series with a median of 52 months (range, 8-143) of follow-up. Twenty patients (90.9%) were able to progress in the single-ventricle pathway with 12 patients (54.5%) undergoing a Fontan operation and 8 patients (36.4%) achieving bidirectional Glenn shunt and awaiting a Fontan operation. Two patients (9.1%) were not suitable to progress to the single-ventricle pathway because of elevated PA pressure. All patients who achieved cavopulmonary connection were alive and asymptomatic with no signs of elevation of PA pressure. No patient required further reinterventions for the PA. CONCLUSIONS: PPAS is not a contraindication for single-ventricle palliation. With careful planning and aggressive early surgical reconstruction, most of these patients can successfully progress to cavopulmonary connections.
引用
- Al-Khaldi A, Alsahari A, Alotay A, et al. Peripheral Pulmonary Artery Stenosis Is Not a Contraindication to a Single-ventricle Pathway. Ann Thorac Surg. 2021. PMID: 33811885. doi:10.1016/j.athoracsur.2021.03.059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。